EUVIMEDEUVIMED entdecken
Crossref

SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer

B. Shay, Z. Evans, C. Conway, Z. Tothova, E. Stover

European Journal of Cancer · 2026-11 · 248 · 117643

DOI: 10.1016/j.ejca.2026.117643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von B. Shay und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shay, B., Evans, Z., Conway, C., Tothova, Z., & Stover, E. (2026). SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer. European Journal of Cancer, 248, 117643. https://doi.org/10.1016/j.ejca.2026.117643

Vancouver

Shay B, Evans Z, Conway C, Tothova Z, Stover E. SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer. European Journal of Cancer. 2026;248:117643. doi:10.1016/j.ejca.2026.117643

BibTeX
@article{Shay2026,
  author = {Shay, B. and Evans, Z. and Conway, C. and Tothova, Z. and Stover, E.},
  title = {SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117643},
  doi = {10.1016/j.ejca.2026.117643}
}
Kostenlos starten →